📣 VC round data is live. Check it out!

Brainscan Valuation Multiples

Discover revenue and EBITDA valuation multiples for Brainscan and similar public comparables like Genetic Analysis, Prostatype Genomics, Spermosens, Cykel AI and more.

Brainscan Overview

About Brainscan

Brainscan SA is an AI system for lesion detection in the human brain based on computed tomography images. Algorithms powered by artificial intelligence analyze CT brain scans, automatically detecting and highlighting potential pathological changes.


Founded

2017

HQ

Poland

Employees

N/A

Financials (FY)

Revenue: $118K
EBITDA: ($759K)

EV

$5M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Brainscan Financials

Brainscan reported last fiscal year revenue of $118K and negative EBITDA of ($759K).

In the same fiscal year, Brainscan generated $113K in gross profit, ($759K) in EBITDA losses, and had net loss of ($779K).


Brainscan P&L

In the most recent fiscal year, Brainscan reported revenue of $118K and EBITDA of ($759K).

Brainscan is unprofitable as of last fiscal year, with gross margin of 96%, EBITDA margin of (644%), and net margin of (661%).

See analyst estimates for Brainscan
Last FY202320242025202620272028
Revenue$118K$15K$59K$118K
Gross Profit$113K$1K$44K$113K
Gross Margin96%7%75%96%
EBITDA($759K)($551K)($1M)($759K)
EBITDA Margin(644%)(3595%)(2233%)(644%)
EBIT Margin(641%)(3755%)(2264%)(641%)
Net Profit($779K)($491K)($1M)($779K)
Net Margin(661%)(3204%)(2395%)(661%)

Financial data powered by Morningstar, Inc.

Brainscan Stock Performance

Brainscan has current market cap of $5M, and enterprise value of $5M.

Market Cap Evolution


Brainscan's stock price is $4.06.

Brainscan share price decreased by 4.0% in the last 30 days, and by 50.4% in the last year.

Brainscan has an EPS (earnings per share) of $-0.61.

See more trading valuation data for Brainscan
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$5M$5M-4.0%-4.0%-40.6%-50.4%$-0.61

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Brainscan Valuation Multiples

Brainscan trades at 38.2x EV/Revenue multiple, and (5.9x) EV/EBITDA.

See NTM and 2027E valuation multiples for Brainscan

Brainscan Financial Valuation Multiples

As of May 8, 2026, Brainscan has market cap of $5M and EV of $5M.

Brainscan has a P/E ratio of (6.6x).

Last FY202320242025202620272028
EV/Revenue38.2xn/m76.3x38.2x
EV/EBITDA(5.9x)(8.2x)(3.4x)(5.9x)
EV/EBIT(6.0x)(7.8x)(3.4x)(6.0x)
EV/Gross Profit39.8xn/m101.9x39.8x
P/E(6.6x)(10.5x)(3.7x)(6.6x)
EV/FCF24.3x(9.1x)(4.2x)24.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Brainscan Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Brainscan Margins & Growth Rates

In the most recent fiscal year, Brainscan reported gross margin of 96%, EBITDA margin of (644%), and net margin of (661%).

See estimated margins and future growth rates for Brainscan

Brainscan Margins

Last FY20242025202720282029
Gross Margin96%75%96%
EBITDA Margin(644%)(2233%)(644%)
EBIT Margin(641%)(2264%)(641%)
Net Margin(661%)(2395%)(661%)
FCF Margin157%(1822%)157%

Brainscan Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth285%100%
Gross Profit Growth4033%156%
EBITDA Growth139%(42%)
EBIT Growth132%(43%)
Net Profit Growth188%(45%)
FCF Growth117%(117%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Brainscan Operational KPIs

Access forward-looking KPIs for Brainscan
Last FY202320242025202620272028
Opex to Revenue737%3762%2339%737%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Genetic Analysis1.6x1.4x(4.6x)(4.9x)
Prostatype Genomics56.8x(0.8x)
Spermosens(3.4x)
Cykel AI
Elite Diagnostic
Level Bio0.6x(14.8x)
Attana7.2x(2.0x)
GenIP6.7x(1.0x)

This data is available for Pro users. Sign up to see all Brainscan competitors and their valuation data.

Start Free Trial

Brainscan Funding History

Before going public, Brainscan raised $2M in total equity funding, across 4 rounds.

Last private valuation of Brainscan was $2M, after raising $300K in April 2019 from LSI (Life Science Innovations Fund).


Brainscan Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Jun-23Series A$1M
Jan-22Pre-seed$500K
Apr-19SeedLSI (Life Science Innovations Fund)$300K$2M
Aug-18Pre-seed$300K

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Brainscan

When was Brainscan founded?Brainscan was founded in 2017.
Where is Brainscan headquartered?Brainscan is headquartered in Poland.
Is Brainscan publicly listed?Yes, Brainscan is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Brainscan?Brainscan trades under BSN ticker.
When did Brainscan go public?Brainscan went public in 2024.
Who are competitors of Brainscan?Brainscan main competitors include Genetic Analysis, Prostatype Genomics, Spermosens, Cykel AI, Elite Diagnostic, Level Bio, Attana, GenIP, Unith, Genomed.
What is the current market cap of Brainscan?Brainscan's current market cap is $5M.
What is the current revenue of Brainscan?Brainscan's last fiscal year revenue is $118K.
What is the current EV/Revenue multiple of Brainscan?Current revenue multiple of Brainscan is 38.2x.
Is Brainscan profitable?No, Brainscan is not profitable.
How many companies Brainscan has acquired to date?Brainscan hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Brainscan has invested to date?Brainscan hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Brainscan

Lists including Brainscan

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial